Leaflet REMIFENTANIL KABI 1mg powder for concentrate for solution for injection / infusion

Product code:
W54953002
Quantity:
5
Indicated for:
analgesia; anesthesia
Route of administration:
injectable / infusion
Substance:
remifentanil (opioid analgesic)
ATC
N01AH06 — Nervous system | Anesthetics | Anesthetics, general | Opioid anesthetics

Precautions:

Driving impairment

Driving impairment

This medicine may affect your ability to drive or use machines.

Dizziness / vertigo

Dizziness / vertigo

This medicine may cause dizziness or vertigo.

Dependence / abuse

Dependence / abuse

This medicine may cause dependence or be misused.

Respiratory depression

Respiratory depression

May slow breathing, especially with alcohol or sedatives.

Avoid alcohol

Avoid alcohol

Avoid alcohol during treatment.

Major drug interactions

Major drug interactions

This medicine may have important interactions with other medicines.

Breastfeeding warning

Breastfeeding warning

Use during breastfeeding only on medical advice.

Pregnancy warning

Pregnancy warning

Use during pregnancy only on medical advice.

Elderly warning

Elderly warning

Older people may have an increased risk of side effects.

Withdrawal / do not stop abruptly

Withdrawal / do not stop abruptly

Do not stop treatment abruptly without medical advice.

Drowsiness / sedation

Drowsiness / sedation

This medicine may cause drowsiness or reduced alertness.

Remifentanil is an opioid analgesic used to control pain during surgical procedures or other medical interventions. It acts quickly and has a short duration of action, making it ideal for use in general anesthesia.

The medication is administered intravenously under the strict supervision of an anesthesiologist. The dosage is adjusted based on the patient's needs and the duration of the procedure.

Side effects may include respiratory depression, low blood pressure, nausea, or muscle rigidity. In rare cases, severe allergic reactions or other complications may occur, requiring immediate medical intervention.

Patients should inform their doctor about any other medications being used or pre-existing conditions, such as respiratory diseases or allergies, to ensure the safe use of remifentanil.

General data about REMIFENTANIL KABI 1mg

Substance:
remifentanil
Date of latest medicines list:
01-06-2026
Product code:
W54953002
Concentration:
1mg
Pharmaceutical form:
powder for concentrate for solution for injection / infusion
Quantity:
5
Product type:
Generic medicine
Price:
120.18 RON
Prescription status:
TAB2 — Medicines dispensed with a special medical prescription for narcotic substances, yellow in color.

Marketing authorisation

Manufacturer:
FRESENIUS KABI DEUTSCHLAND GMBH - GERMANIA
Holder:
FRESENIUS KABI ROMANIA S.R.L. - ROMANIA
Number:
6935/2014/02
Shelf life:
2 years-after packing for marketing;after reconstitutiona/diluarea sol.-it is used immediately

Concentrations available for remifentanil

  • 1mg
  • 2mg
  • 5mg